Literature DB >> 25156674

Temporal associations between the different domains of rheumatoid arthritis disease activity and the onset of patient-reported depressive symptoms.

Alan M Rathbun1, Leslie R Harrold, George W Reed.   

Abstract

BACKGROUND: Depression is a frequently occurring comorbid condition in patients with rheumatoid arthritis (RA), and research into the temporal relationships regarding its onset has mainly focused on functional status. The study aim was to examine temporal associations of the diverse measures of RA disease activity with incident self-reports of depressive symptoms.
METHODS: RA patients from the Consortium of Rheumatology Researchers of North America (CORRONA) registry were utilized. Cox regression was used to assess the lagged time-varying association of RA disease activity with the incident onset of depressive symptoms as measured using a single-item depression question. Predictor variables included joint counts, global assessments, pain, function, serum biomarkers, and composite disease activity. Hazard ratios (HRs) comparing categorical quintiles were estimated with 95 % confidence intervals.
RESULTS: Every metric of disease activity, except inflammatory markers, were significantly associated with the self-reported onset of depressive symptoms. Adjusted HRs comparing fifth quintiles to first quintiles were the following: CDAI = 2.3 [2.1-2.7]; pain = 2.3 [2.0-2.6]; SJC = 1.4 [1.4-1.6]. When examining successive self-reports (two consecutive), the magnitude of the associations greatly increased: CDAI = 3.6 [2.5-5.0].
CONCLUSIONS: The data suggest depressive symptom onset in RA patients is related to measures reported by the patient: pain, functional status, and global disease activity; and measures reported by providers, rather than biological markers. The magnitude of the associations, however, were greater for the patient-reported measures when compared to physician assessments, implying that patients' experience of their disease activity may be a precipitating factor of depression onset.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25156674     DOI: 10.1007/s10067-014-2759-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  47 in total

1.  Longterm predictors of anxiety and depressed mood in early rheumatoid arthritis: a 3 and 5 year followup.

Authors:  Andrea W M Evers; Floris W Kraaimaat; Rinie Geenen; Johannes W G Jacobs; Johannes W J Bijlsma
Journal:  J Rheumatol       Date:  2002-11       Impact factor: 4.666

2.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

3.  Developing brief scales for use in clinical practice: the reliability and validity of single-item self-report measures of depression symptom severity, psychosocial impairment due to depression, and quality of life.

Authors:  Mark Zimmerman; Camilo J Ruggero; Iwona Chelminski; Diane Young; Michael A Posternak; Michael Friedman; Daniela Boerescu; Naureen Attiullah
Journal:  J Clin Psychiatry       Date:  2006-10       Impact factor: 4.384

4.  Converting modified health assessment questionnaire (HAQ), multidimensional HAQ, and HAQII scores into original HAQ scores using models developed with a large cohort of rheumatoid arthritis patients.

Authors:  Jaclyn Anderson; Harlan Sayles; Jeffrey R Curtis; Fred Wolfe; Kaleb Michaud
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-10       Impact factor: 4.794

5.  Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis.

Authors:  Dennis C Ang; Hyon Choi; Kurt Kroenke; Frederick Wolfe
Journal:  J Rheumatol       Date:  2005-06       Impact factor: 4.666

6.  Functional ability, social support, and depression in rheumatoid arthritis.

Authors:  D M Doeglas; Th P B M Suurmeijer; W J A van den Heuvel; B Krol; M H van Rijswijk; M A van Leeuwen; R Sanderman
Journal:  Qual Life Res       Date:  2004-08       Impact factor: 4.147

7.  Comparative assessment of Yale Single Question and Beck Depression Inventory Scale in screening for depression in multiple sclerosis.

Authors:  Jagannadha R Avasarala; Anne H Cross; Kathryn Trinkaus
Journal:  Mult Scler       Date:  2003-06       Impact factor: 6.312

8.  Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.

Authors:  Daniel Aletaha; Valerie P K Nell; Tanja Stamm; Martin Uffmann; Stephan Pflugbeil; Klaus Machold; Josef S Smolen
Journal:  Arthritis Res Ther       Date:  2005-04-07       Impact factor: 5.156

9.  Depression in adults, including those with a chronic physical health problem: summary of NICE guidance.

Authors:  Stephen Pilling; Ian Anderson; David Goldberg; Nicholas Meader; Clare Taylor
Journal:  BMJ       Date:  2009-10-27

10.  Sad, blue, or depressed days, health behaviors and health-related quality of life, Behavioral Risk Factor Surveillance System, 1995-2000.

Authors:  Rosemarie Kobau; Marc A Safran; Matthew M Zack; David G Moriarty; Daniel Chapman
Journal:  Health Qual Life Outcomes       Date:  2004-07-30       Impact factor: 3.186

View more
  11 in total

1.  Temporal effect of depressive symptoms on the longitudinal evolution of rheumatoid arthritis disease activity.

Authors:  Alan M Rathbun; Leslie R Harrold; George W Reed
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-05       Impact factor: 4.794

2.  Pain severity as a mediator of the association between depressive symptoms and physical performance in knee osteoarthritis.

Authors:  A M Rathbun; M D Shardell; E A Stuart; M S Yau; J J Gallo; M S Schuler; M C Hochberg
Journal:  Osteoarthritis Cartilage       Date:  2018-08-06       Impact factor: 6.576

3.  A Prospective Evaluation of the Effects of Prevalent Depressive Symptoms on Disease Activity in Rheumatoid Arthritis Patients Treated With Biologic Response Modifiers.

Authors:  Alan M Rathbun; Leslie R Harrold; George W Reed
Journal:  Clin Ther       Date:  2016-06-29       Impact factor: 3.393

4.  Dynamic Effects of Depressive Symptoms on Osteoarthritis Knee Pain.

Authors:  Alan M Rathbun; Elizabeth A Stuart; Michelle Shardell; Michelle S Yau; Mona Baumgarten; Marc C Hochberg
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-12-06       Impact factor: 4.794

5.  Depression Subtypes in Individuals With or at Risk for Symptomatic Knee Osteoarthritis.

Authors:  Alan M Rathbun; Megan S Schuler; Elizabeth A Stuart; Michelle D Shardell; Michelle S Yau; Joseph J Gallo; Alice S Ryan; Marc C Hochberg
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-05       Impact factor: 4.794

6.  Association between disease progression and depression onset in persons with radiographic knee osteoarthritis.

Authors:  Alan M Rathbun; Michelle D Shardell; Alice S Ryan; Michelle S Yau; Joseph J Gallo; Megan S Schuler; Elizabeth A Stuart; Marc C Hochberg
Journal:  Rheumatology (Oxford)       Date:  2020-11-01       Impact factor: 7.580

7.  Are we missing the diagnosis of depression in patients with rheumatoid arthritis at a tertiary care facility?

Authors:  Ammara Masood; Babur Salim; Amjad Nasim; Ziaullah Khalid; Amir Afzal
Journal:  Pak J Med Sci       Date:  2017 Mar-Apr       Impact factor: 1.088

8.  Depressive symptoms and the risk of arthritis: A survival analysis using data from the osteoarthritis initiative.

Authors:  Vishal Vennu; Harsh Misra; Asha Misra
Journal:  Indian J Psychiatry       Date:  2019 Sep-Oct       Impact factor: 1.759

9.  Predictors of unacceptable pain with and without low inflammation over 5 years in early rheumatoid arthritis-an inception cohort study.

Authors:  Anna Eberhard; Stefan Bergman; Thomas Mandl; Tor Olofsson; Maria Rydholm; Lennart Jacobsson; Carl Turesson
Journal:  Arthritis Res Ther       Date:  2021-06-14       Impact factor: 5.156

10.  Relationship Between Depression and Disease Activity in United States Veterans With Early Rheumatoid Arthritis Receiving Methotrexate.

Authors:  Alan M Rathbun; Bryant R England; Ted R Mikuls; Alice S Ryan; Jennifer L Barton; Michelle D Shardell; Marc C Hochberg
Journal:  J Rheumatol       Date:  2020-11-15       Impact factor: 5.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.